These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 20798235)

  • 1. Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features.
    Kumar S; Dispenzieri A; Katzmann JA; Larson DR; Colby CL; Lacy MQ; Hayman SR; Buadi FK; Leung N; Zeldenrust SR; Ramirez-Alvarado M; Clark RJ; Kyle RA; Rajkumar SV; Gertz MA
    Blood; 2010 Dec; 116(24):5126-9. PubMed ID: 20798235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantation.
    Sidiqi MH; Aljama MA; Muchtar E; Buadi FK; Warsame R; Lacy MQ; Dispenzieri A; Dingli D; Leung N; Gonsalves WI; Kumar SK; Kapoor P; Kourelis TV; Hogan WJ; Gertz MA
    Blood Adv; 2018 Apr; 2(7):769-776. PubMed ID: 29615413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The prognostic value of baseline serum free light chain in immunoglobulin light-chain cardiac amyloidosis].
    Wang LM; Wang TT; Tian Y; Zhao L; Yang XC; Chen WM
    Zhonghua Xue Ye Xue Za Zhi; 2020 Jan; 41(1):47-53. PubMed ID: 32023754
    [No Abstract]   [Full Text] [Related]  

  • 4. Patients with light-chain amyloidosis and low free light-chain burden have distinct clinical features and outcome.
    Milani P; Basset M; Russo F; Foli A; Merlini G; Palladini G
    Blood; 2017 Aug; 130(5):625-631. PubMed ID: 28546143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The diagnostic and prognostic values of serum free light chain in patients with primary light chain amyloidosis].
    Zhang CL; Feng J; Shen KN; Su W; Zhang CL; Huang XF; Cao XX; Zhang L; Zhou DB; Li J
    Zhonghua Xue Ye Xue Za Zhi; 2016 Nov; 37(11):942-945. PubMed ID: 27995877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The prognostic value of baseline serum free light chain in cardiac amyloidosis].
    Zhao L; Tian Z; Fang Q
    Zhonghua Nei Ke Za Zhi; 2016 Mar; 55(3):186-90. PubMed ID: 26926369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acid sequence homology of monoclonal serum free light chain dimers and tissue deposited light chains in AL amyloidosis: a pilot study.
    Goldis R; Kaplan B; Arad M; Dispenzieri A; Dasari S; Kukuy OL; Simon AJ; Dori A; Shavit-Stein E; Ziv T; Murray D; Kourelis T; Gertz MA; Dominissini D; Magen H; Muchtar E
    Clin Chem Lab Med; 2024 Feb; 62(3):464-471. PubMed ID: 37747270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of light chain isotype on clinical features and outcomes in systemic AL amyloidosis.
    Hopson MB; Bhutani D; Sarkaria S; Maurer MS; Griffin JM; Mapara M; Lentzsch S; Chakraborty R
    Leuk Lymphoma; 2022 Sep; 63(9):2109-2113. PubMed ID: 35465769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A patient with AL amyloidosis with negative free light chain results.
    Milani P; Valentini V; Ferraro G; Basset M; Russo F; Foli A; Palladini G; Merlini G
    Clin Chem Lab Med; 2016 Jun; 54(6):1035-7. PubMed ID: 26677890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin-related (AL) amyloidosis.
    Husby G
    Clin Exp Rheumatol; 1983; 1(4):353-8. PubMed ID: 6442636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
    Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
    Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains.
    Sidana S; Tandon N; Dispenzieri A; Gertz MA; Buadi FK; Lacy MQ; Dingli D; Fonder AL; Hayman SR; Hobbs MA; Gonsalves WI; Hwa YL; Kapoor P; Kyle RA; Leung N; Go RS; Lust JA; Russell SJ; Zeldenrust SR; Rajkumar SV; Kumar SK
    Leukemia; 2018 Mar; 32(3):729-735. PubMed ID: 28919633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.
    Katzmann JA; Clark RJ; Abraham RS; Bryant S; Lymp JF; Bradwell AR; Kyle RA
    Clin Chem; 2002 Sep; 48(9):1437-44. PubMed ID: 12194920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of free light chain before and after chemotherapy in primary systemic AL amyloidosis.
    Matsuda M; Yamada T; Gono T; Shimojima Y; Ishii W; Fushimi T; Sakashita K; Koike K; Ikeda S
    Intern Med; 2005 May; 44(5):428-33. PubMed ID: 15942088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic approach to and follow-up of difficult cases of AL amyloidosis.
    Perfetti V; Garini P; Vignarelli MC; Marinone MG; Zorzoli I; Merlini G
    Haematologica; 1995; 80(5):409-15. PubMed ID: 8566880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capillary electrophoresis/immunosubtraction as a better alternative to immunofixation for detecting and immunotyping serum monoclonal proteins in patients with immunoglobulin light chain (AL) amyloidosis.
    Miyazaki K; Suzuki K
    Amyloid; 2016 Dec; 23(4):221-224. PubMed ID: 27682970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical presentation and prognosis in patients with light-chain amyloidosis with an ultra-high level of serum free light-chain].
    Miao HL; Shen KN; Su W; Zhang L; Cao XX; Zhou DB; Li J
    Zhonghua Xue Ye Xue Za Zhi; 2021 Mar; 42(3):199-204. PubMed ID: 33910304
    [No Abstract]   [Full Text] [Related]  

  • 18. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders.
    Dispenzieri A; Kyle R; Merlini G; Miguel JS; Ludwig H; Hajek R; Palumbo A; Jagannath S; Blade J; Lonial S; Dimopoulos M; Comenzo R; Einsele H; Barlogie B; Anderson K; Gertz M; Harousseau JL; Attal M; Tosi P; Sonneveld P; Boccadoro M; Morgan G; Richardson P; Sezer O; Mateos MV; Cavo M; Joshua D; Turesson I; Chen W; Shimizu K; Powles R; Rajkumar SV; Durie BG;
    Leukemia; 2009 Feb; 23(2):215-24. PubMed ID: 19020545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inter-assay variability in automated serum free light chain assays and their use in the clinical laboratory.
    Caponi L; Romiti N; Koni E; Fiore AD; Paolicchi A; Franzini M
    Crit Rev Clin Lab Sci; 2020 Mar; 57(2):73-85. PubMed ID: 31612753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in serum-free light chain rather than intact monoclonal immunoglobulin levels predicts outcome following therapy in primary amyloidosis.
    Kumar SK; Dispenzieri A; Lacy MQ; Hayman SR; Buadi FK; Zeldenrust SR; Tan T; Sinha S; Leung N; Kyle RA; Rajkumar SV; Gertz MA
    Am J Hematol; 2011 Mar; 86(3):251-5. PubMed ID: 21328431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.